MICHELLE WHATLEY: Open Payments
NPI 1891318333 · ROYSTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$766 in 39 payments from 13 companies in 2025. Trend: 2023 $229 · 2024 $182 · 2025 $766
Food & beverage: $766
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $266 |
| ABBVIE INC. | 10 | $158 |
| Axsome Therapeutics, Inc. | 4 | $74 |
| Lilly USA, LLC | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Verona Pharma, Inc. | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Lundbeck LLC | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| PFIZER INC. | 1 | $21 |
Products named: REXULTI, UBRELVY, Auvelity, MOUNJARO, Ohtuvayre, TRINTELLIX, TRELEGY ELLIPTA, CREON.
Industry payments across GA — which companies pay providers there.
